The next firms are anticipated to report earnings previous to market open on 11/14/2022. Go to our Earnings Calendar for a full listing of anticipated earnings releases.
Tyson Meals, Inc. (TSN)is reporting for the quarter ending September 30, 2022. The meat product firm’s consensus earnings per share forecast from the 4 analysts that comply with the inventory is $1.70. This worth represents a 26.09% lower in comparison with the identical quarter final 12 months. Prior to now 12 months TSN has beat the expectations each quarter. The very best one was within the 2nd calendar quarter the place they beat the consensus by 1.57%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for TSN is 7.56 vs. an business ratio of 5.60, implying that they are going to have a better earnings development than their rivals in the identical business.
AECOM (ACM)is reporting for the quarter ending September 30, 2022. The engineering firm’s consensus earnings per share forecast from the three analysts that comply with the inventory is $0.84. This worth represents a 3.70% enhance in comparison with the identical quarter final 12 months. Prior to now 12 months ACM has met analyst expectations as soon as and beat the expectations the opposite three quarters. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for ACM is 22.95 vs. an business ratio of -42.00, implying that they are going to have a better earnings development than their rivals in the identical business.
DENTSPLY SIRONA Inc. (XRAY)is reporting for the quarter ending September 30, 2022. The medical/dental provides firm’s consensus earnings per share forecast from the 7 analysts that comply with the inventory is $0.59. This worth represents a 13.24% lower in comparison with the identical quarter final 12 months. XRAY missed the consensus earnings per share within the 4th calendar quarter of 2021 by -3.8%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for XRAY is 12.89 vs. an business ratio of 21.40.
Tower Semiconductor Ltd. (TSEM)is reporting for the quarter ending September 30, 2022. The electrical firm firm’s consensus earnings per share forecast from the two analysts that comply with the inventory is $0.56. This worth represents a 55.56% enhance in comparison with the identical quarter final 12 months. Prior to now 12 months TSEM has beat the expectations each quarter. The very best one was within the 2nd calendar quarter the place they beat the consensus by 1.92%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for TSEM is nineteen.08 vs. an business ratio of two.60, implying that they are going to have a better earnings development than their rivals in the identical business.
monday.com Ltd. (MNDY)is reporting for the quarter ending September 30, 2022. The web software program firm’s consensus earnings per share forecast from the three analysts that comply with the inventory is $-1.20. This worth represents a 84.62% lower in comparison with the identical quarter final 12 months. Prior to now 12 months MNDY has beat the expectations each quarter. The very best one was within the 2nd calendar quarter the place they beat the consensus by 25.19%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for MNDY is -16.96 vs. an business ratio of -70.30, implying that they are going to have a better earnings development than their rivals in the identical business.
Roivant Sciences Ltd. (ROIV)is reporting for the quarter ending September 30, 2022. The biomedical (gene) firm’s consensus earnings per share forecast from the two analysts that comply with the inventory is $-0.41. This worth represents a 52.87% enhance in comparison with the identical quarter final 12 months. Zacks Funding Analysis reviews that the 2023 Value to Earnings ratio for ROIV is -3.01 vs. an business ratio of 0.00.
Thoughtworks Holding, Inc. (TWKS)is reporting for the quarter ending September 30, 2022. The expertise companies firm’s consensus earnings per share forecast from the 5 analysts that comply with the inventory is $0.01. This worth represents a 111.11% enhance in comparison with the identical quarter final 12 months. TWKS missed the consensus earnings per share within the 1st calendar quarter of 2022 by -137.5%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for TWKS is 824.00 vs. an business ratio of 15.30, implying that they are going to have a better earnings development than their rivals in the identical business.
Clear Safe, Inc. (YOU)is reporting for the quarter ending September 30, 2022. The safety security firm’s consensus earnings per share forecast from the two analysts that comply with the inventory is $0.00. This worth represents a 100.00% enhance in comparison with the identical quarter final 12 months. Prior to now 12 months YOU has beat the expectations each quarter. The very best one was within the 2nd calendar quarter the place they beat the consensus by 100%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for YOU is -488.80 vs. an business ratio of 34.70.
360 DigiTech, Inc. (QFIN)is reporting for the quarter ending September 30, 2022. The expertise companies firm’s consensus earnings per share forecast from the 1 analyst that follows the inventory is $0.92. This worth represents a 39.47% lower in comparison with the identical quarter final 12 months. QFIN missed the consensus earnings per share within the 2nd calendar quarter of 2022 by -7.07%. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for QFIN is 3.49 vs. an business ratio of 15.30.
FREYR Battery (FREY)is reporting for the quarter ending September 30, 2022. The choice power firm’s consensus earnings per share forecast from the two analysts that comply with the inventory is $-0.29. This worth represents a 30.95% enhance in comparison with the identical quarter final 12 months. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for FREY is -12.19 vs. an business ratio of 10.60.
Oatly Group AB (OTLY)is reporting for the quarter ending September 30, 2022. The dairy firm’s consensus earnings per share forecast from the 6 analysts that comply with the inventory is $-0.11. This worth represents a 57.14% lower in comparison with the identical quarter final 12 months. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for OTLY is -4.31 vs. an business ratio of 149.00.
Viridian Therapeutics, Inc. (VRDN)is reporting for the quarter ending September 30, 2022. The biomedical (gene) firm’s consensus earnings per share forecast from the 6 analysts that comply with the inventory is $-0.87. This worth represents a 30.40% enhance in comparison with the identical quarter final 12 months. Zacks Funding Analysis reviews that the 2022 Value to Earnings ratio for VRDN is -5.29 vs. an business ratio of 0.00.
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.
